Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 7/20 | 0.43 |
| ▸ | MAP3K5 | Q99683 | 2/20 | 0.35 |
| ▸ | MAP3K6 | O95382 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.34 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | AXL | P30530 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.33 |
| ▸ | PDE5A | O76074 | 1/20 | 0.33 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL984226 | 0.93 | LRRK2 (0.40) | BTKMAP3K5MAP3K6PTK2LRRK2 | |
| SCHEMBL983483 | 0.92 | BTK (0.35) | BTKMAP3K5MAP3K6PTK2LRRK2 | |
| SCHEMBL985437 | 0.91 | BTK (0.37) | BTKMAP3K5MAP3K6PTK2LRRK2 | |
| Hydrochloric Acid SCHEMBL985105 | 0.91 | PTK2 (0.40) | KDM1APTK2HTR2AHTR2CHTR2B | |
| SCHEMBL982398 | 0.90 | BTK (0.34) | BTKMAP3K5MAP3K6PTK2LRRK2 | |
| SCHEMBL981748 | 0.89 | BTK (0.39) | BTKLRRK2PDE4BRIPK2 | |
| SCHEMBL985449 | 0.89 | BTK (0.35) | BTKMAP3K5MAP3K6PTK2LRRK2 | |
| SCHEMBL981750 | 0.89 | BTK (0.39) | BTKLRRK2PDE4BRIPK2 | |
| SCHEMBL982064 | 0.89 | MAP3K5 (0.37) | BTKMAP3K5MAP3K6LRRK2 | |
| SCHEMBL986220 | 0.88 | PTK2 (0.40) | KDM1APTK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110021479-A1 | PYRROLOPYRIMIDINECARBOXAMIDES | NYCOMED GMBH (DE) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021479-A1 | PYRROLOPYRIMIDINECARBOXAMIDES | PDE5A, PDE3A, PDE2A | BTK 1977/4885MAP3K5 1564/4885MAP3K6 2724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.